Research overview
About CJC-1295 No DAC
CJC-1295 variants are synthetic GHRH analogs. The No DAC designation distinguishes this short-acting presentation from the longer-acting drug-affinity-complex form described in published studies.
Research use only
GHRH-pathway research
CJC-1295 No DAC
10 mg
$99.99
A short-acting GHRH-analog research material studied in pituitary and growth-hormone signaling models.
Laboratory research only
Research context included
For laboratory research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or prevention of disease.
Areas of investigation
GHRH receptor signaling
Pituitary-response models
Growth-hormone pathways
Analog metabolism
Scholarly references